Marilena Vrana: The Final Day of IPPC 2026
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared a post on LinkedIn:
“The final day of IPPC 2026 was incredibly impactful.
The day got off to a fast start with David Osgathorp, a leading expert on professional performance and resilience from Red Bull Racing and Red Bull Technology.
His lessons learned from working with professional athletes set the tone for a dynamic and engaging panel on the next generation of leadership in the unique plasma sector.
I will be reflecting on some of these profound insights as my own career continues in this space.
The panel set the direction for how PPTA Europe can further engage and support the next generation.
Today’s final panels pushed us to think bigger about donor health and safety, as well as what it would really take to boost plasma collection in Europe.
International Plasma Protein Congress is an opportunity for ideas to turn into action, and this year truly delivered.
Already looking ahead to IPPC2027 in Barcelona, now less than a year away.
Let’s keep the momentum going!
See you on 20-21 April 2027.
More posts featuring Marilena Vrana on Hemostasis Today.
-
Jun 25, 2026, 15:56Wolfgang Miesbach: Building the Future of Gene Therapy – From Centre Readiness to Long-Term Patient Care
-
Jun 25, 2026, 15:46Amber Yates: Making a Meaningful Difference for People Living with Sickle Cell Disease
-
Jun 25, 2026, 15:43Nancy Cavey: Navigating Disability Benefits for Patients with Immune Thrombocytopenia
-
Jun 25, 2026, 15:28Damon Race: Pursuing Long-Term Expression in Hemophilia A Gene Therapy
-
Jun 25, 2026, 15:23Jonas Kingo: ISTH 2026 in Paris Brings the Global Hemostasis Community Together
-
Jun 25, 2026, 15:21Balancing Therapeutic Progress and Emergency Preparedness in Hemophilia – CRH French Reference Center for Hemophilia Lyon
-
Jun 25, 2026, 15:06Ifeanyichukwu Ifechidere: What If One of the Biggest Myth Fact About APS is Hidden in its Name?
-
Jun 25, 2026, 15:05Gopal Patidar: Advancing Haemovigilance and Global Collaboration at ISBT 2026
-
Jun 25, 2026, 14:52Violeta Jardin: Measuring Antifibrinolytic Effect to Improve Tranexamic Acid Safety